Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide 500 Accuhaler mechanistic study in COPD
2009-015876-86Phase 4Unknown
- Sponsor
- University Hospital Southampton
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University Hospital Southampton. Primary endpoint: Change in cell population and activation. Status: unknown.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-015876-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015876-86.